Regeneron Pharmaceuticals, Inc. specializes in the discovery, development, and commercialization of treatments for serious medical conditions. The company's primary focus is on biotechnology, developing medicines for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases.
Founded in 1988 by Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos, Regeneron is headquartered in Tarrytown, New York, USA.
Regeneron is known for its innovative medicines, including treatments for eye diseases, high LDL cholesterol, atopic dermatitis, asthma, and rheumatoid arthritis. It is also known for its VelociSuite technologies, which are used in drug discovery and development.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Leonard S. Schleifer M.D., Ph.D. | Co-Founder, President, CEO & Co-Chairman | 7M | N/A | 1953 |
| Dr. George D. Yancopoulos M.D., Ph.D. | Co-Founder, President, Chief Scientific Officer & Co-Chairman | 6.59M | N/A | 1960 |
| Mr. Robert E. Landry Jr. | Executive VP of Finance & CFO | 1.84M | 11.1M | 1964 |
| Dr. Andrew J. Murphy Ph.D. | Executive Vice President of Research | 1.62M | 19.39M | 1959 |
| Mr. Daniel P. Van Plew | Executive VP and GM of Industrial Operations & Product Supply | 1.95M | 45.28M | 1973 |
| Ms. Marion E. McCourt | Executive Vice President of Commercial | 1.5M | 4.25M | 1960 |
| Ms. Patrice Gilooly | Senior Vice President of Quality Assurance & Operations | N/A | N/A | N/A |
| Mr. Christopher R. Fenimore CPA | Senior VP, Head of Accounting & Controller | N/A | N/A | 1971 |
| Mr. Gerald Underwood | Senior Vice President of Technical Operations | N/A | N/A | N/A |
| Mr. Bob McCowan | Senior VP of IT & Chief Information Officer | N/A | N/A | N/A |
Charts and financial information provided by TradingView, a popular charting & trading platform.
Check out even more advanced features or grab charts for your website.
This post has been viewed 10 times.
